Concepedia

Ricardo Pasqüini

RP

Statistics

Publications

131

Citations

13.1K

H-Index

48

Active since

1983

Affiliations

Universidade Federal do Paraná(Current)

Hospital de Clínicas Universidade Federal do Paraná

Universidade de São Paulo

The University of Texas MD Anderson Cancer Center

Universidade Estadual de Campinas (UNICAMP)

Ricardo Pasqüini is an author at Universidade Federal do Paraná specializing in medicine, hematology, and stem cell transplantation.

ORCID

Publications per year

1983–2023

131

Publications

131

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

, , +10

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

, , +10

Outcome of Cord-Blood Transplantation from Related and Unrelated Donors

Éliane Gluckman, Vanderson Rocha, Agnès Boyer-Chammard et al. · New England Journal of Medicine · 1997 · 1.3K citations · Full text

, , +12

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf et al. · Blood · 2011 · 461 citations

, , +9

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Hagop Kantarjian, Ricardo Pasqüini, Nelson Hamerschlak et al. · Blood · 2007 · 378 citations · Full text

, , +5

1–5 of 131